Indivior Pharmaceuticals INDV
NASDAQ INDV
$36.16 -0.43 (-1.17%)
As of: Sep 30, 2026 · 12:51 PM EDT

Indivior Pharmaceuticals, Inc. (INDV) Capital Expenditures (2024 - 2026)

Updated

Indivior Pharmaceuticals (INDV) reported Capital Expenditures of $7 million for Q2 2026, down 58.8% from $17 million a year earlier and down 65.0% from the prior quarter.

Analysis

Indivior Pharmaceuticals, Inc. (INDV) Capital Expenditures (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Indivior Pharmaceuticals' Capital Expenditures came in at $71 million, up 57.8% year-over-year; for FY2025, it was $66 million, up 127.6% from FY2024.

  • Capital Expenditures has increased for four consecutive years, with a four-year compound annual growth rate of 101.5% (FY2021 to FY2025).
  • By year, Capital Expenditures came in at $29 million in FY2024 (+262.5%), $8 million in FY2023 (+60.0%), $5 million in FY2022 (+25.0%) and $4 million in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Capital Expenditures since Q1 2025.
  • Year over year, Capital Expenditures gained in five of the last six quarters, with growth averaging 158.6%.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $20 million (Q1 2026), $24 million (Q4 2025) and $20 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.00 Mn
Mar 31, 2026 20.00 Mn
Dec 31, 2025 24.00 Mn
Sep 30, 2025 20.00 Mn
Jun 30, 2025 17.00 Mn
Mar 31, 2025 5.00 Mn
Dec 31, 2024 16.00 Mn
Sep 30, 2024 7.00 Mn
Jun 30, 2024 4.00 Mn
Mar 31, 2024 2.00 Mn
API Access

Indivior Pharmaceuticals, Inc. Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=INDV&period=max&api_key=YOUR_API_KEY